| Typicality: | 0.382 |
| Saliency: | 0.309 |
| with low-grade lymphomas | 9 | other |
| currently | 5 | temporal |
| during clinical trials | 4 | temporal |
| vaccine → be tested in → patient | 10 |
| vaccine → be tested in → people | 9 |
| vaccine → be tested on → people | 7 |
| vaccine → be tested on → patient | 3 |
| negative | neutral | positive |
| 0.183 | 0.688 | 0.129 |
| Raw frequency | 29 |
| Normalized frequency | 0.309 |
| Modifier score | 0.500 |
| Perplexity | 46.150 |